IP Library Granted Patent US 10,676,796
Granted Patent B2
US 10,676,796 · App. 16/167,737 · Granted Jun 9, 2020

Compositions for detecting BV-associated bacterial nucleic acid

Inventor: Damon K. Getman (Poway, CA)
Assignee: GEN-PROBE INCORPORATED
C12Q1/689
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,676,796
App. No.
16/167,737
Granted
Jun 9, 2020
Kind
B2
Abstract

Disclosed are nucleic acid oligomers, including amplification oligomers, capture probes, and detection probes, for detection of a 16S rRNA or its encoding gene from bacterial species associated with bacterial vaginosis. Also disclosed are methods of specific nucleic acid amplification and detection using the disclosed oligomers, as well as corresponding reaction mixtures and kits.

Claims (19)

1. A reaction mixture for detection of a Megasphaera sp. target nucleic acid, said reaction mixture comprising:

(a) detection probe oligomer comprising

(i) a detection probe target-hybridizing sequence that consists of the sequence of SEQ ID NO:24; and

(ii) a chemiluminescent or fluorescent label; and

(b) an oligomer combination for amplification of a target region of the Megasphaera sp. target nucleic acid, wherein the target region contains the detection probe oligomer target sequence, said oligomer combination comprising

(i) a first amplification oligomer comprising a first target-hybridizing sequence that consists of the sequence of SEQ ID NO:15; and

(ii) a second amplification oligomer comprising a second target-hybridizing sequence that consists of the sequence of SEQ ID NO:21.

2. The reaction mixture of claim 1 , wherein the label is a chemiluminescent label.

3. The reaction mixture of claim 1 , wherein the label is a fluorescent label.

4. The reaction mixture of claim 3 , wherein the detection probe oligomer further comprises a quencher.

5. The reaction mixture of claim 4 , wherein the detection probe oligomer is a TaqMan detection probe or a molecular beacon.

6. The reaction mixture of claim 1 , wherein the detection probe oligomer further comprises a non-target-hybridizing sequence.

7. The reaction mixture of claim 6 , wherein the detection probe oligomer is a hairpin detection probe.

8. The reaction mixture of claim 7 , wherein the hairpin detection probe oligomer is a molecular beacon or a molecular torch.

9. The reaction mixture of claim 1 , wherein the second amplification oligomer is a promoter primer further comprising a promoter sequence located 5′ to the second target-hybridizing sequence.

10. The reaction mixture of claim 9 , wherein the promoter sequence is a T7 promoter sequence.

11. The reaction mixture of claim 9 , wherein the T7 promoter sequence consists of the sequence of SEQ ID NO:22.

12. The reaction mixture of claim 1 , further comprising a capture probe oligomer for purifying the Megasphaera sp. target nucleic acid.

13. The reaction mixture of claim 1 , further comprising a pseudotarget oligomer for detuning sensitivity of an assay for detecting the Megasphaera target nucleic acid.

Assignments (5)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 054089/0804 Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED; FAXITRON BIOPTICS, LLC; GEN-PROBE PRODESSE, INC.
Reel/Frame 075504/0575 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 15, 2020
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 054089/0804 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2020
From: GETMAN, DAMON K.
To: GEN-PROBE INCORPORATED
Reel/Frame 052497/0176 →
SECURITY INTEREST Recorded Oct 14, 2019
From: HOLOGIC, INC.; CYNOSURE, LLC; CYTYC CORPORATION; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 050719/0701 →